Article
Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi.
PloS one - 13 Feb 2008
Bell David J, Nyirongo Suzgo K, Mukaka Mavuto, Zijlstra Ed E, Plowe Christopher V, Molyneux Malcolm E, Ward Steve A, Winstanley Peter A
Abstract excerpt
BACKGROUND: In Malawi, there has been a return of Plasmodium falciparum sensitivity to chloroquine (CQ) since sulfadoxine-pyrimethamine (SP) replaced CQ as first line treatment for uncomplicated malaria. When used for prophylaxis, Amodiaquine (AQ) was associated with agranulocytosis but is considered safe for treatment and is increasingly being used in Africa. Here we compare the efficacy, safety and selection of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
